These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1562 related items for PubMed ID: 25936327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Schatz U, Arneth B, Siegert G, Siegels D, Fischer S, Julius U, Bornstein SR.
    Atheroscler Suppl; 2013 Jan; 14(1):115-22. PubMed ID: 23357152
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P, Banké-Bochita J.
    Arzneimittelforschung; 2010 Jan; 60(6a):362-72. PubMed ID: 20648928
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC.
    Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
    [Abstract] [Full Text] [Related]

  • 7. The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.
    Covic A, Mircescu G.
    Nephrol Dial Transplant; 2010 Aug; 25(8):2722-30. PubMed ID: 20190247
    [Abstract] [Full Text] [Related]

  • 8. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT.
    Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR.
    Arzneimittelforschung; 2010 Feb; 60(6a):386-98. PubMed ID: 20648930
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
    Naqash A, Ara R, Bader GN.
    BMC Womens Health; 2018 Jan 05; 18(1):6. PubMed ID: 29304848
    [Abstract] [Full Text] [Related]

  • 11. Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients.
    Malone M, Barish C, He A, Bregman D.
    Obes Surg; 2013 Sep 05; 23(9):1413-20. PubMed ID: 23553506
    [Abstract] [Full Text] [Related]

  • 12. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
    Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C, FERGI Study Group.
    Gastroenterology; 2011 Sep 05; 141(3):846-853.e1-2. PubMed ID: 21699794
    [Abstract] [Full Text] [Related]

  • 13. Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice.
    Stein J, Aksan A, Klemm W, Nip K, Weber-Mangal S, Dignass A.
    J Crohns Colitis; 2018 Jun 28; 12(7):826-834. PubMed ID: 29955835
    [Abstract] [Full Text] [Related]

  • 14. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA, Keating GM.
    Drugs; 2009 Jun 28; 69(6):739-56. PubMed ID: 19405553
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous ferric carboxymaltose for iron deficiency anemia in dialysis patients: Effect of a new protocol adopted for a hemodialysis limited assistance center.
    Gobbi L, Scaparrotta G, Rigato M, Cattarin L, Qassim L, Carraro G, Rossi B, Calò LA.
    Ther Apher Dial; 2020 Dec 28; 24(6):642-647. PubMed ID: 32154642
    [Abstract] [Full Text] [Related]

  • 19. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R, Kriplani A, Mogili KD, Bhatla N, Kachhawa G, Saxena R.
    Int J Gynaecol Obstet; 2016 Apr 28; 133(1):43-8. PubMed ID: 26868063
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.